Equities

Charlotte's Web Holdings Inc

Charlotte's Web Holdings Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CAD)0.20
  • Today's Change0.01 / 5.26%
  • Shares traded2.76k
  • 1 Year change-34.43%
  • Beta1.9420
Data delayed at least 15 minutes, as of Nov 15 2024 14:57 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Charlotte's Web Holdings, Inc. (Charlotte’s) is engaged in providing hemp extract wellness products under a family of brands which includes Charlotte’s Web, CBD Medic, CBD Clinic, and Harmony Hemp. Charlotte’s Web branded products start with its hemp genetics that are 100% North American farm grown and manufactured into hemp extracts containing naturally occurring phytocannabinoids, including cannabidiol (CBD), cannabichromene (CBC), cannabigerol (CBG), cannabinol (CBN), terpenes, flavonoids and other beneficial hemp compounds. Charlotte’s Web product categories include full spectrum hemp extract oil tinctures (liquid products), gummies (sleep, calm, immunity, exercise recovery, daily wellness, THC-free), capsules, topical creams and lotions, as well as CBD pet products for dogs. Charlotte’s Web products are distributed to retail outlets and health care practitioners, as well as online through the Company’s Website at www.Charlottesweb.com.

  • Revenue in CAD (TTM)76.68m
  • Net income in CAD-62.44m
  • Incorporated2018
  • Employees164.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Kane Biotech Inc757.12k-5.48m16.48m--------21.77-0.0420.03740.0059-0.00550.15680.37513.23---113.43-77.89----60.5443.27-723.31-241.850.5679-4.731.43---94.42-20.26-17.29---19.41--
Devonian Health Group Inc9.75m-3.17m19.27m6.00--1.44--1.98-0.0216-0.02160.06650.090.442333.072.321,625,238.00-14.37-21.02-23.15-23.9630.9529.96-32.50-131.971.06-9.410.1406--1.74-5.83-33.39------
Medipharm Labs Corp37.76m-13.49m28.77m166.00--0.6043--0.7621-0.0378-0.03780.10330.11580.56622.753.82227,451.80-20.22-32.88-24.86-39.5623.80-5.88-35.72-67.662.33--0.0557--49.4926.5256.37---49.66--
Charlotte's Web Holdings Inc76.68m-62.44m29.92m164.00--0.5942--0.3902-0.4046-0.40460.49590.31980.35611.3425.09467,583.80-29.00-25.71-33.48-29.0348.0748.98-81.43-63.112.07-42.570.5481---14.82-1.9059.88---7.88--
Decibel Cannabis Company Inc101.04m-563.00k30.98m----0.66479.430.3066-0.0016-0.00960.23490.10530.75551.646.86---0.421-3.55-0.6781-5.1926.7015.77-0.5572-7.130.3644-3.030.5178--46.18--60.33---32.45--
Medicus Pharma Ltd0.00-16.49m35.25m----3.89-----3.58-3.580.000.83610.00-------267.24-652.37-371.17-------------20.260.0549-------300.86------
Data as of Nov 15 2024. Currency figures normalised to Charlotte's Web Holdings Inc's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.